Detalhe da pesquisa
1.
Determination of essential biomarkers in lung cancer: a real-world data study in Spain with demographic, clinical, epidemiological and pathological characteristics.
BMC Cancer
; 22(1): 732, 2022 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35790916
2.
Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using real-life data.
BMC Cancer
; 21(1): 977, 2021 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34465283
3.
Second-line treatment in advanced non-small-cell lung cancer in the epidermal growth factor receptor wild-type population: review of patient profile.
Anticancer Drugs
; 25(4): 368-74, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24384805
4.
PD-1/PD-L1 Inhibitors as Monotherapy in the First-Line Treatment of Advanced Non-Small Cell Lung Cancer Patients with High PD-L1 Expression: An Expert Position Statement.
J Clin Med
; 12(15)2023 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37568465
5.
Real-world data with afatinib in Spanish patients with treatment-naïve non-small-cell lung cancer harboring exon 19 deletions in epidermal growth factor receptor (Del19 EGFR): Clinical experience of the Galician Lung Cancer Group.
Cancer Treat Res Commun
; 33: 100646, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36335799
6.
The LNK Gene Family: At the Crossroad between Light Signaling and the Circadian Clock.
Genes (Basel)
; 10(1)2018 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30577529
7.
Labial dystonia after facial and trigeminal neuropathy controlled with a maxillary splint.
Mov Disord
; 22(9): 1355-8, 2007 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17486646
8.
Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: a lung cancer Galician group phase II study.
Cancer Chemother Pharmacol
; 60(5): 725-32, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17273825
9.
EGFR testing and clinical management of advanced NSCLC: a Galician Lung Cancer Group study (GGCP 048-10).
Cancer Manag Res
; 8: 11-20, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26893581
10.
Docetaxel plus epirubicin is a highly active, well-tolerated, first-line chemotherapy for metastatic breast cancer: results of a large, multicentre phase II study.
Cancer Chemother Pharmacol
; 53(1): 75-81, 2004 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-14557896
11.
Full-dose cisplatin and oral vinorelbine concomitant with radiotherapy in unresectable stage III non-small cell lung cancer: a multi-center phase II study.
Anticancer Res
; 34(4): 1959-66, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24692732
12.
Biweekly XELOX (capecitabine and oxaliplatin) as first-line treatment in elderly patients with metastatic colorectal cancer.
J Geriatr Oncol
; 4(2): 114-21, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24071536
13.
First-line bevacizumab, cisplatin and vinorelbine plus maintenance bevacizumab in advanced non-squamous non-small cell lung cancer chemo-naïve patients.
Expert Opin Pharmacother
; 13(10): 1389-96, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22630129
14.
Biweekly administration of docetaxel and vinorelbine as second-line chemotherapy for patients with stage IIIB and IV non-small cell lung cancer: a phase II study of the Galician Lung Cancer Group (GGCP 013-02).
Anticancer Drugs
; 18(10): 1201-6, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17893521
15.
Interleukin-2 for the treatment of solid tumors other than melanoma and renal cell carcinoma.
Anticancer Drugs
; 17(1): 1-12, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16317284